Artiva Biotherapeutics, Inc. Common Stock (ARTV)

Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $332M; returns 1 day -0.8%, 1 week +5.1%, 1 year +27.1%.

Artiva Biotherapeutics, Inc. (ARTV) is a clinical-stage biotechnology company developing natural killer (NK) cell-based therapies for patients with autoimmune diseases and various cancers. The company's core strategy revolves around its "Manufacturing-First" approach to produce highly effective, off-the-shelf, allogeneic NK cell therapies.

Groups ARTV belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Autoimmune Diseases
• Clinical Stage
• Immunotherapy
• Fast Track Designation
• Oncology
• Cancer Therapeutics

ARTV financial model: income statement, cash flow and balance sheet